SVA — Sinovac Biotech Cashflow Statement
0.000.00%
HealthcareMicro Cap
Annual cashflow statement for Sinovac Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 14,120 | -60 | -121 | 40.7 | -199 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 44 | 129 | -122 | -31.2 | 52.2 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 562 | -941 | 238 | -123 | -377 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 15,322 | -798 | 139 | -56.9 | -512 |
| Capital Expenditures | -594 | -314 | -156 | -97.6 | -49.1 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2,381 | -5,780 | -2,543 | 554 | 4,437 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,975 | -6,094 | -2,699 | 456 | 4,388 |
| Financing Cash Flow Items | -1,876 | -235 | -328 | -947 | -3,534 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,913 | -300 | -88.6 | -824 | -3,435 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10,570 | -7,733 | -2,758 | -527 | 554 |